Get the Stockscreener App
0.4023
1.70%
0.009
Fibrobiologics Inc stock is traded at $0.4023, with a volume of 228.62K.
It is up +1.70% in the last 24 hours and down -27.17% over the past month.
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
See More
Previous Close:
$0.3933
Open:
$0.382
24h Volume:
228.62K
Relative Volume:
0.31
Market Cap:
$16.61M
Revenue:
-
Net Income/Loss:
$-17.78M
P/E Ratio:
-0.7325
EPS:
-0.5492
Net Cash Flow:
$-10.52M
1W Performance:
-7.58%
1M Performance:
-27.17%
6M Performance:
-60.40%
1Y Performance:
-87.42%
1-Day Range:
$0.382
$0.4028
1-Week Range:
$0.3805
$0.4399
52-Week Range:
$0.3805
$3.89
Fibrobiologics Inc Stock (FBLG) Company Profile
Name
Fibrobiologics Inc
Sector
Industry
Phone
281-671-5150
Address
455 E. MEDICAL CENTER BLVD, HOUSTON
Compare FBLG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FBLG
Fibrobiologics Inc
|
0.3966 | 16.47M | 0 | -17.78M | -10.52M | -0.5492 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.50 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
638.23 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.90 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.39 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.24 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-30-24 | Initiated | H.C. Wainwright | Buy |
| Sep-24-24 | Initiated | Maxim Group | Buy |
Fibrobiologics Inc Stock (FBLG) Latest News
FBLG Analyst Ratings: Jason Kolbert Maintains Buy Stance | FBLG Stock News - GuruFocus
How FibroBiologics Inc. stock performs in interest rate cyclesPortfolio Performance Summary & Fast Moving Stock Trade Plans - newser.com
How sustainable is FibroBiologics Inc. stock dividend payoutPortfolio Growth Summary & Capital Efficiency Focused Ideas - newser.com
What’s the recovery path for long term holders of FibroBiologics Inc.July 2025 News Drivers & Expert Approved Momentum Trade Ideas - newser.com
Identifying reversal signals in FibroBiologics Inc.Weekly Profit Report & Community Verified Trade Signals - newser.com
Sector ETF performance correlation with FibroBiologics Inc.Trade Analysis Report & Verified Chart Pattern Trade Signals - newser.com
How FibroBiologics Inc. (SG0) stock performs in easing cyclesWeekly Loss Report & Verified Stock Trade Ideas - newser.com
How dovish Fed policy supports FibroBiologics Inc. (SG0) stockAnalyst Upgrade & Weekly Watchlist of Top Performers - newser.com
What earnings revisions data tells us about FibroBiologics Inc.Market Performance Summary & Capital Protection Trade Alerts - newser.com
Real time scanner hits for FibroBiologics Inc. explainedStock Surge & Free Technical Confirmation Trade Alerts - newser.com
Analyzing recovery setups for FibroBiologics Inc. investorsQuarterly Trade Report & Breakout Confirmation Alerts - newser.com
What data driven models say about FibroBiologics Inc.’s futureTrade Signal Summary & Short-Term High Return Strategies - newser.com
Why institutional investors increase stakes in FibroBiologics Inc. (SG0) stock2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
FibroBiologics, Inc. (FBLG) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
What drives FibroBiologics Inc stock priceTrading Volume Surges & Free Tools to Monitor Market Corrections - earlytimes.in
FibroBiologics Advances Manufacturing and IND Preparations for Clinical Trials of CYWC628, CYPS317, and CYMS101 - Quiver Quantitative
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
FibroBiologics, Inc. SEC 10-Q Report - TradingView
FibroBiologics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
FibroBiologics warns on going concern amid $15M notes - Stock Titan
Is FibroBiologics Inc. stock gaining market shareMarket Activity Recap & Precise Buy Zone Tips - newser.com
Is FibroBiologics Inc. (SG0) stock resilient in recession scenarios2025 Short Interest & Fast Moving Trade Plans - newser.com
Is FibroBiologics Inc. (SG0) stock ideal for retirement investors2025 Momentum Check & Weekly Return Optimization Alerts - newser.com
Why FibroBiologics Inc. stock appeals to dividend seekersPortfolio Risk Report & Real-Time Market Trend Scan - newser.com
Fibrobiologics Inc Stock (FBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.21%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):